MASLD/MetALD/MAFLD/NAFLD的临床特征以及对代谢障碍的相对风险分析
Hong-Ye Peng1,2, Chun-Li Lu3, Mo Zhao2
1Department of Infection, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China.
BMC gastroenterology
|May 14, 2025
概括
代谢功能障碍相关的脂肪性肝病 (MASLD) 和代谢性酒精相关的肝病 (MetALD) 的定义是有价值的. 与代谢相关的脂肪肝疾病 (MAFLD) 是识别患有高风险代谢疾病 (如高血压和2型糖尿病) 的患者的强有力的指标.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 代谢障碍 代谢障碍 代谢障碍
- 流行病学 流行病学
背景情况:
- 非酒精性脂肪性肝病 (NAFLD) 是一个越来越令人担忧的问题.
- 提出了新的定义,如代谢功能障碍相关的脂肪性肝病 (MASLD) 和代谢性酒精相关的肝病 (MetALD).
- 代谢相关脂肪肝疾病 (MAFLD) 已成为一个独立的实体.
研究的目的:
- 为了比较MASLD,MetALD,MAFLD和NAFLD的临床特征.
- 分析与这些肝脏疾病相关的代谢障碍的相对风险.
主要方法:
- 利用了2017-2018年国家健康和营养检查调查的数据.
- 使用多变量调整后勤回归模型进行风险分析.
- 包括1862名符合条件的参与者.
主要成果:
- 发病率: MASLD (44.84%),MetALD (11.44%),MAFLD (45.17%),NAFLD (60.42%). 这两种疾病的发病率均高于其他疾病的发病率.
- 在所有肝病和高血压,2型糖尿病 (T2DM) 和高脂血症之间发现了显著的关联.
- 与中度至重度肥胖症相关的MASLD,MAFLD和NAFLD与轻度肥胖症相比,显示T2DM风险更高.
结论:
- 关于MASLD和MetALD的定义需要进一步研究.
- MAFLD在识别具有代谢障碍风险较高的个体方面表现出更大的有效性.
- 这项研究强调了肝病的精确诊断标准在管理代谢健康方面的重要性.
更多相关视频
08:35A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium
Published on: May 18, 2021
6.1K
08:41Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
1.0K
相关概念视频
Overview of Lipid Metabolism
876
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
876
Inborn Errors of Metabolism
116
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
116
Overview of Protein Metabolism
605
Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
605
Diseases of the Liver and Gallbladder
393
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
393
